At1g63010 Antibody

What is At1g63010 and what are its known cellular functions?

At1g63010 is an SPX domain-containing-like protein identified in vacuolar membrane (tonoplast) proteomic studies in Arabidopsis thaliana. Proteomic analysis has revealed it contains approximately 10 transmembrane domains with a molecular weight of 78 kDa and an isoelectric point (pI) of 6.0 . The protein shares sequence homology (68%) with certain barley proteins and appears alongside other SPX domain-containing proteins like At4g22990 and At4g11810 . While specific functions remain under investigation, its presence in the tonoplast fraction suggests potential roles in vacuolar transport processes, possibly related to phosphate homeostasis, which is a common function of SPX domain proteins.

What structural features characterize the At1g63010 protein?

Proteomic analysis indicates At1g63010 contains:

• Approximately 10 transmembrane domains (TMDs)

• A molecular weight of approximately 78 kDa

• An isoelectric point (pI) of approximately 6.0

• An SPX domain, which typically functions in phosphate signaling and homeostasis

• A protein prediction score of 0.99, indicating high confidence in its identification

The multiple transmembrane domains indicate it is an integral membrane protein, likely with both cytosolic and vacuolar lumen-facing domains that could be targeted by antibodies.

How does At1g63010 relate to other characterized plant proteins?

At1g63010 belongs to a family of SPX domain-containing proteins that includes several close homologs:

This sequence similarity poses potential challenges for antibody specificity, requiring careful epitope selection to avoid cross-reactivity with these related proteins. Additionally, the protein appears in proteomic datasets alongside vacuolar membrane proteins like V-ATPase subunits and other tonoplast transporters , suggesting potential functional relationships within vacuolar transport systems.

What criteria should guide the selection of antibodies against At1g63010?

When selecting antibodies for At1g63010 research, consider:

• Epitope specificity:

  • Target unique regions that distinguish At1g63010 from homologs (At4g22990, At4g11810)

  • Avoid conserved SPX domains that might lead to cross-reactivity

  • Consider antibodies against multiple epitopes for validation

• Antibody format:

  • Polyclonal antibodies: Provide higher sensitivity but potentially lower specificity

  • Monoclonal antibodies: Offer higher specificity but may have limited epitope recognition

  • Recombinant antibodies: Provide consistent reproducibility between batches

• Application compatibility:

  • Western blot: Verify denaturation compatibility considering membrane protein properties

  • Immunolocalization: Confirm epitope accessibility in fixed tissues

  • Immunoprecipitation: Ensure antibody functions under native conditions

• Validation documentation:

  • Request evidence of testing in knockout/knockdown plants

  • Review specificity data showing absence of cross-reactivity with related proteins

  • Check for proper subcellular localization consistent with tonoplast proteins

What experimental approaches effectively validate At1g63010 antibody specificity?

A comprehensive validation protocol should include:

• Genetic validation:

  • Test antibodies on wild-type vs. At1g63010 knockout/knockdown lines

  • Examine overexpression lines for increased signal intensity

  • Compare with tagged At1g63010 lines using tag-specific antibodies

• Biochemical validation:

  • Peptide competition assays to confirm epitope specificity

  • Western blot analysis showing bands at the expected molecular weight (~78 kDa)

  • Subcellular fractionation showing enrichment in tonoplast membrane preparations, similar to known vacuolar markers

  • Mass spectrometry confirmation of immunoprecipitated proteins

• Cross-reactivity assessment:

  • Test against recombinant At1g63010 and closely related proteins

  • Examine related SPX-domain protein knockout lines for persistent signal

  • Pre-absorption with recombinant At1g63010 should eliminate specific signal

The validation approach can be modeled after protocols used for other vacuolar membrane proteins, as demonstrated in the tonoplast proteomic study that identified At1g63010 .

How can immunopurification enhance At1g63010 antibody performance?

For challenging applications requiring enhanced antibody performance:

• Affinity purification methods:

  • Use recombinant At1g63010 protein fragments for affinity purification

  • Employ negative selection against related proteins to remove cross-reactive antibodies

  • Sequential affinity purification can significantly enhance specificity

• Epitope-specific purification:

  • Purify antibodies against specific peptide sequences unique to At1g63010

  • Validate purified fractions against multiple plant genotypes

  • Test purified antibodies in parallel applications to determine optimal fraction

• Performance enhancement strategies:

  • Optimize antibody concentration through titration experiments

  • Determine ideal buffer conditions that maximize signal-to-noise ratio

  • Consider using antibody fragments (Fab, F(ab')2) to reduce background in some applications

• Validation of purified antibodies:

  • Compare purified vs. unpurified antibody performance

  • Document specificity improvements through western blot and immunolocalization

  • Verify that purification doesn't compromise detection sensitivity

What are optimal protocols for membrane protein extraction when studying At1g63010?

Membrane protein extraction requires specialized approaches:

• Vacuolar membrane enrichment:

  • Protoplast isolation followed by vacuole purification

  • Verify enrichment using marker enzymes as shown in this reference table:

• Extraction buffer optimization:

  • Include detergents appropriate for membrane proteins (0.5-1% Triton X-100, NP-40, or CHAPS)

  • Use high pH buffers (pH 8-9) to maintain protein stability

  • Add protease inhibitors to prevent degradation

  • Consider phosphatase inhibitors if studying phosphorylation states

• Membrane solubilization techniques:

  • Avoid boiling samples, instead incubate at 37-50°C to prevent aggregation

  • Use gentle sonication or dounce homogenization to maximize protein extraction

  • Perform sequential extractions to improve recovery

• Fractionation approaches:

  • Density gradient centrifugation for membrane separation

  • Two-phase partitioning for plasma membrane vs. intracellular membrane separation

  • Use both KI and NaOH treatments to distinguish peripheral from integral membrane proteins

What immunolocalization techniques are most effective for visualizing At1g63010 in plant tissues?

For optimal immunolocalization results:

• Tissue preparation considerations:

  • Use chemical fixation with 4% paraformaldehyde or 2% glutaraldehyde

  • Consider cryo-fixation methods for membrane protein preservation

  • Optimize fixation time to maintain epitope accessibility (typically 1-4 hours)

  • Perform careful cell wall digestion for whole-mount preparations

• Membrane protein-specific approaches:

  • Use detergent concentrations sufficient for membrane permeabilization (0.1-0.5% Triton X-100)

  • Apply gentle antigen retrieval methods (citrate buffer, pH 6.0)

  • Block with BSA (3-5%) rather than milk proteins to reduce background

• Signal detection systems:

  • Use high-sensitivity fluorescent secondary antibodies for confocal microscopy

  • Consider signal amplification systems (tyramide signal amplification) for low-abundance proteins

  • Perform co-localization with established tonoplast markers (V-ATPase subunits identified in the same proteomic study )

• Controls and validation:

  • Include peptide competition controls

  • Compare localization patterns in wild-type vs. knockout tissue

  • Verify patterns against fluorescent protein fusions where available

How can At1g63010 antibodies facilitate protein interaction studies?

Antibody-based interaction studies should consider:

• Co-immunoprecipitation strategies:

  • Extract proteins under non-denaturing conditions

  • Optimize detergent type and concentration to maintain native interactions

  • Pre-clear lysates to reduce non-specific binding

  • Compare results under different phosphate availability conditions

• Proximity-based interaction methods:

  • Use antibodies to validate BioID or APEX2 proximity labeling results

  • Confirm physical interactions identified through yeast two-hybrid screens

  • Investigate potential interactions with other tonoplast proteins identified in the same proteomic study

• In situ interaction visualization:

  • Proximity ligation assays (PLA) to visualize protein interactions in fixed tissues

  • Co-localization analysis with confocal microscopy

  • FRET-based approaches with labeled antibodies

• Specialized membrane protein interaction approaches:

  • Detergent-resistant membrane microdomain analysis

  • Blue native PAGE followed by western blotting

  • Chemical crosslinking prior to immunoprecipitation

How should discrepancies between antibody-based and transcript-based measurements of At1g63010 be interpreted?

When facing discrepancies:

• Biological explanations:

  • Post-transcriptional regulation affects protein-to-mRNA ratios

  • Protein half-life may differ significantly from mRNA stability

  • Translational efficiency can vary under different conditions

  • Compartmentalization may affect protein detection but not transcript levels

• Methodological considerations:

  • Antibody epitope accessibility may be affected by post-translational modifications

  • Membrane protein extraction efficiency varies between protocols

  • Transcript detection methods have different sensitivity thresholds than protein methods

  • Normalization approaches differ between proteomic and transcriptomic analyses

• Validation approaches:

  • Use multiple antibodies targeting different epitopes

  • Compare results from different protein quantification methods

  • Perform time-course analyses to identify temporal disconnects between mRNA and protein

  • Examine protein degradation rates through cycloheximide chase experiments

• Data integration strategies:

  • Develop mathematical models incorporating both transcript and protein data

  • Consider both measurements as complementary rather than contradictory

  • Validate key findings using genetic approaches (overexpression, knockout)

What common technical challenges arise when working with At1g63010 antibodies and how can they be addressed?

Common challenges and solutions include:

• Weak or inconsistent western blot signal:

  • Optimize membrane protein extraction methods

  • Use larger protein amounts (50-100 μg) for membrane proteins

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use enhanced detection systems (chemiluminescent substrates with extended activity)

  • Consider alternative detergents for improved solubilization

• High background in immunolocalization:

  • Increase blocking time and concentration (5% BSA, 2-3 hours)

  • Add 0.1-0.3% Tween-20 to antibody dilution buffers

  • Perform more extensive washing steps (6-8 washes, 10 minutes each)

  • Pre-adsorb antibodies with plant tissue powder from knockout lines

  • Optimize fixation to reduce non-specific binding

• Non-specific bands in western blots:

  • Use gradient gels for better resolution

  • Include controls with knockout/knockdown plant material

  • Perform peptide competition controls

  • Optimize primary antibody concentration through serial dilutions

  • Consider affinity purification to improve specificity

• Failed co-immunoprecipitation:

  • Test multiple detergent conditions to maintain protein interactions

  • Use reversible crosslinking to stabilize transient interactions

  • Verify antibody functionality in native conditions

  • Increase starting material for membrane proteins

What statistical approaches should be applied to quantitative analyses of At1g63010 protein levels?

For rigorous quantitative analysis:

• Western blot quantification:

  • Normalize to appropriate membrane protein loading controls

  • Use at least three biological replicates and technical duplicates

  • Verify signal linearity across a concentration range

  • Apply appropriate statistical tests (t-test, ANOVA) with correction for multiple comparisons

• Immunolocalization quantification:

  • Measure signal intensity across multiple cells and tissues

  • Calculate signal-to-background ratios

  • Apply appropriate segmentation to isolate subcellular compartments

  • Use colocalization coefficients for comparative studies

• Relative vs. absolute quantification:

  • Use recombinant protein standards for absolute quantification

  • Apply appropriate curve fitting for standard curves

  • Report confidence intervals and coefficient of variation

  • Consider spike-in controls for cross-experiment normalization

• Advanced statistical approaches:

  • Use mixed-effects models to account for both technical and biological variation

  • Consider Bayesian approaches for small sample sizes

  • Perform power analysis to determine appropriate sample sizes

  • Apply correlation analysis when comparing with other variables

How can At1g63010 antibodies contribute to understanding vacuolar transport mechanisms?

Advanced applications include:

• Regulatory mechanism investigation:

  • Monitor protein levels under different nutrient conditions

  • Examine post-translational modifications using phospho-specific antibodies

  • Study protein turnover rates through pulse-chase experiments

  • Investigate potential interacting partners through co-immunoprecipitation

• Structure-function analysis:

  • Use epitope-specific antibodies to study conformational changes

  • Examine accessibility of different protein domains

  • Correlate structural features with transport activity

  • Map functional domains through antibody inhibition studies

• Physiological role determination:

  • Compare protein levels across developmental stages

  • Examine response to environmental stresses

  • Correlate protein levels with vacuolar content and transport activities

  • Study genetic interactions through analysis in different mutant backgrounds

• Systems biology integration:

  • Combine antibody-based protein quantification with metabolomics

  • Correlate with vacuolar pH and ion content measurements

  • Integrate into larger models of vacuolar transport and function

  • Map At1g63010 within tonoplast protein interaction networks

What approaches can distinguish between At1g63010 and closely related SPX-domain proteins in experimental settings?

Distinguishing between homologous proteins requires:

• Epitope mapping strategies:

  • Design epitope-specific antibodies targeting unique regions

  • Perform alanine scanning mutagenesis to identify critical binding residues

  • Use computational predictions to identify accessible, unique epitopes

  • Validate specificity using knockout lines for each related protein

• Protein-specific detection methods:

  • Combine immunoprecipitation with mass spectrometry to identify specific peptides

  • Use antibody arrays with multiple antibodies targeting different epitopes

  • Apply subtractive approaches comparing different genetic backgrounds

  • Employ CRISPR-edited protein variants with altered epitopes

• Functional distinction approaches:

  • Compare localization patterns between homologs

  • Analyze knockout phenotypes and complementation

  • Study differential responses to environmental conditions

  • Examine physical interactions with different partner proteins

• Cross-reactivity management:

  • Perform antibody pre-absorption with recombinant homologous proteins

  • Use immunodepletion strategies to remove cross-reacting antibodies

  • Apply competitive ELISAs to quantify relative affinities

  • Validate with orthogonal approaches (GFP fusions, epitope tagging)

How can At1g63010 antibody studies integrate with broader phosphate homeostasis research?

Integration strategies include:

• Multilevel experimental design:

  • Compare At1g63010 protein levels across phosphate availability conditions

  • Correlate with intracellular phosphate levels and distribution

  • Examine co-regulation with other phosphate transporters and SPX-domain proteins

  • Study interaction with known phosphate signaling components

• Comparative physiology approaches:

  • Analyze At1g63010 expression patterns in multiple plant species

  • Examine conservation of regulation and localization

  • Compare functional roles in phosphate-efficient vs. inefficient species

  • Study evolutionary relationships between SPX-domain proteins

• Applied research connections:

  • Investigate potential roles in phosphate use efficiency

  • Examine expression in plants grown under different agricultural conditions

  • Study correlation with phosphate stress tolerance

  • Explore potential for genetic improvement of phosphate utilization

• Technology integration:

  • Combine antibody studies with phosphoproteomics

  • Integrate with genetic mapping of phosphate efficiency traits

  • Correlate with metabolomic profiling of phosphate-containing metabolites

  • Apply imaging approaches to study spatial distribution in tissues